Date:5/3/2012

continuing operations$
-$ (0.01)$
-$
.20Weighted Average Number of Diluted Shares Outstanding349.5352.9349.2351.8We apply varying tax rates depending on the item's nature and tax jurisdiction where it is incurred.(1) Includes a $54.7 million decrease in the fair value of the total contingent consideration obligation related to the P4 Healthcare acquisition for the three months ended March 31, 2012. The related tax expense was $20.1 million and diluted EPS from continuing operations increased $0.10.(2) The sum of the components may not equal the total due to rounding.Schedule 9CARDINAL HEALTH, INC. AND SUBSIDIARIESASSET MANAGEMENT ANALYSISThird QuarterYear-to-Date2012201120122011Days Sales Outstanding21.219.7Days Inventory on Hand25.024.5Days Payable Outstanding38.338.0Net Working Capital Days7.96.2Debt to Total Capital29 %30 %Net Debt to Capital2 %8 %Return on Equity21.9 %17.8 %18.7 %18.7 %Non-GAAP Return on Equity21.6 %20.7 %19.4 %19.1 %Effective Tax Rate from Continuing Operations34.9 %41.3 %36.9 %35.5 %Non-GAAP Effective Tax Rate from Continuing Operations35.6 %39.7 %37.1 %36.5 %Refer to the GAAP/Non-GAAP reconciliation for Non-GAAP calculations. Refer to DSO, DIOH and DPO for definitions and calculations.Schedule 10

CARDINAL HEALTH, INC. AND SUBSIDIARIES
GAAP / NON-GAAP RECONCILIATIONS

(in millions, except per Common Share amounts)Third Quarter 2012EarningsBeforeEarningsDilutedIncomeProvisionEarningsfromDilutedEPS fromOperatingTaxes andforfromContinuingEPS fromContinuingOperatingEarningsDiscontinuedIncomeContinuingOperationsContinuingOperationsEarningsGrowth RateOperationsTaxes(1)OperationsGrowth RateOperationsGrowth RateGAAP$
52718 %$
510$
78$
33233 %$
.9534 %Restructuring and Employee Severance77

3

40.01Acquisition-Related Costs(27)(27)

'/>"/>

SOURCE Cardinal Health, Inc. Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22
Related medicine technology :

1. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
2. Stem Cell Breakthrough Advances Science Without Ethical Landmines, Says Cardinal
3. Hydrox Inc., Cardinal Health Issue Nationwide Recall of Alcohol-Free Mouthwash For Hospitals
4. Cardinal Health Completes Enturia Acquisition
5. Cardinal Health Expands PET Nuclear Pharmacy Services to Support Clinical Drug Trials
6. AmeriCares Honors Cardinal Health with Power of Partnership Award
7. Cardinal Health Helps Hospitals Save More Than $20 Million In Pharmaceutical Costs; Connect Low-Income Patients With Affordable Medications
8. Cardinal Health Executives to Speak at Two Investor Events in January
9. Cardinal Health Names Carrie Cox to Board of Directors
10. Cardinal Health Raises Quarterly Dividend By 11 Percent
11. Cardinal Health Supports ACRIN Clinical Trials Evaluating Oncologic Biotracers